Pneumonia Clinical Trial
Official title:
Assessing the Health Impact of Advance Water Filters and Improved Cookstoves in Western Province, Rwanda: A Cluster-randomised Controlled Trial
DelAgua Health Rwanda (Implementation) Ltd. together with Rwanda Ministry of Health (MoH)
are delivering an intervention, consisting on the free distribution of one advance water
filter and one improved cookstove to all household classified as ubudehe 1 and 2 according
to government approved registers (poorest tertile), in Western Province. The aim of this
intervention is to reduce the morbidity and mortality associated with diarrhoeal diseases
and pneumonia in Rwanda.
The London School of Hygiene and Tropical Medicine (LSHTM) will be undertaking an
independent evaluation of this large-scale intervention to assess its impact on health. The
trial will evaluate whether the provision of improved cookstoves and advance water filters
can reduce pneumonia and diarrhoea disease in children under 5 years of age.
A cluster randomized controlled trial (CRCT) with two arms of unequal size (3:1 ratio) will
be use to answer this question. The 96 sectors in Western Province, Rwanda, will be
randomised to either receive the intervention or the control. Each eligible household in
intervention sectors will receive one EcoZoom™ Spartan and one Vestergaard Frandsen
Lifestraw Family™ 2.1 water filter free of charge. Eligible households in control sectors
will continue with their traditional cooking and drinking practices. Health data on children
under 5 years of age will be collected from community health worker (CHW) and health
facility records all across Western Province to evaluate the health impact of the
intervention. The study will encompass 12 months of follow-up. After this time the control
sectors will receive the intervention.
This independent evaluation will also include a nested village-level study within the larger
sector-level study, with the aim to evaluate uptake, consistent use and acceptability of the
intervention, as well as to assess the impact on environmental exposures and health
outcomes. 174 villages (74 controls and 74 intervention) will be selected for participation.
Household surveys will be used to collect data on intervention use and acceptability as well
as on self-reported health data. Water samples will be collected and monitoring of exposure
to Households Air Pollution (HAP) will be undertaken. Measurements of blood pressure,
expirated Carbon monoxide (CO) and pulse CO-oximetry will be undertake in primary cooks and
or children under 5 years of age. Additionally, as part of this nested study, two
exploratory studies will also be conducted. One will be focused on assessing the potential
of biomarkers as indicators of environmental exposures (mainly HAP and water quality) and
health status, while the other exploratory sub-study will assess the reactivity of
participants to the use of remotely reporting electronic sensors to measure target
behaviours.
n/a
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04244474 -
Effect of Vitamin D Supplementation on Improvement of Pneumonic Children
|
Phase 1/Phase 2 | |
Completed |
NCT05815264 -
Clinical Trial of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Chinese Population Aged 2 Years and Above
|
Phase 1 | |
Recruiting |
NCT04589936 -
Prone Position to Improve Oxygenation in COVID-19 Patients Outside Critical Care
|
N/A | |
Completed |
NCT02905383 -
The Effect of Exercise on Physical Function and Health in Older People After Discharge From Hospital
|
N/A | |
Terminated |
NCT03944551 -
Bubble Continuous Positive Airway Pressure for Children With Severe Pneumonia in Mali, Africa
|
N/A | |
Completed |
NCT06210737 -
A Study to Evaluate Persistence of Immunity of PCV13 in Healthy Population Aged 2 Months,7 Months-5 Years
|
Phase 4 | |
Terminated |
NCT04660084 -
Impact of Molecular Testing on Improved Diagnosis, Treatment and Management of CAP
|
N/A | |
Not yet recruiting |
NCT05649891 -
Checklists Resuscitation Emergency Department
|
N/A | |
Withdrawn |
NCT05702788 -
Efficacy and Safety of Jaktinib in Participants With Severe Novel Coronavirus Pneumonia(COVID-19)
|
Phase 2 | |
Not yet recruiting |
NCT04171674 -
Pharmacokinetics of High-dose Ceftobiprole in Community-acquired Pneumonia Under Mechanical Ventilation.
|
N/A | |
Active, not recruiting |
NCT03140163 -
Screening for Pneumonia: A Comparison of Ultra Low Dose Chest CT [ULD-CT] and Conventional Chest Radiography [CXR]
|
N/A | |
Completed |
NCT02864420 -
Hospitalization at Home: The Acute Care Home Hospital Program for Adults
|
N/A | |
Completed |
NCT02638649 -
Prehospital Use of Ultrasound in Undifferentiated Shortness of Breath
|
||
Recruiting |
NCT02515565 -
Physiotherapy in Patients Hospitalized Due to Pneumonia.
|
N/A | |
Completed |
NCT02105298 -
Effect of Volume and Type of Fluid on Postoperative Incidence of Respiratory Complications and Outcome (CRC-Study)
|
N/A | |
Completed |
NCT01416519 -
Physiotherapy Technique Decreases Respiratory Complications After Cardiac Operation
|
N/A | |
Completed |
NCT01446926 -
Study of Investigational Pneumococcal Vaccine in Healthy Adults, Toddlers and Infants
|
Phase 1 | |
Completed |
NCT01399723 -
Amoxicillin Versus Benzyl Penicillin for Treatment of Children Hospitalised With Severe Pneumonia
|
Phase 3 | |
Terminated |
NCT02358642 -
Drug to Prevent Pneumonia in the Tube Fed
|
Phase 4 | |
Completed |
NCT01476995 -
Prognostic Indicators as Provided by the EPIC ClearView
|
N/A |